Sample Size Determination in Clinical Trials with an Emphasis on Exponentially Distributed Responses
From MaRDI portal
Publication:3201541
DOI10.2307/2531541zbMATH Open0715.62238OpenAlexW2326104523WikidataQ41442365 ScholiaQ41442365MaRDI QIDQ3201541FDOQ3201541
B. Christine Clark, Alan J. Gross, Hurshell H. Hunt, Alan B. Cantor
Publication date: 1987
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2531541
Recommendations
- Sample size determination for grouped exponential observations: a cost function approach
- Fixed and sequential treatment allocation in clinical trials
- Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
- Determination of the optimal sample size for a clinical trial accounting for the population size
- Nonparametric Estimation of Duration of Accrual and Total Study Length for Clinical Trials
clinical trialsSample sizeexpected trial costexponentially distributed responsesoptimal length of trial
Cited In (6)
- Sample size determination in clinical trials with multiple endpoints
- Most stable sample size determination in clinical trials
- SOME OBSERVATIONS ON THE MAKUCH/SIMON APPROACH TO SAMPLE SIZE DETERMINATION IN CLINICAL TRIALS WITH HISTORICAL CONTROLS
- Sample size calculations for noninferiority trials with Poisson distributed count data
- Cost-efficient clinical studies with continuous time survival outcomes
- Sample size selection in clinical trials when population means are subject to a partial order: one-sided ordered alternatives
This page was built for publication: Sample Size Determination in Clinical Trials with an Emphasis on Exponentially Distributed Responses
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201541)